Enteropathy-associated T-cell lymphoma classification

Jump to navigation Jump to search

Enteropathy-associated T-cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Enteropathy-associated T-cell lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Enteropathy-associated T-cell lymphoma classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Enteropathy-associated T-cell lymphoma classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Enteropathy-associated T-cell lymphoma classification

CDC on Enteropathy-associated T-cell lymphoma classification

Enteropathy-associated T-cell lymphoma classification in the news

Blogs on Enteropathy-associated T-cell lymphoma classification

Risk calculators and risk factors for Enteropathy-associated T-cell lymphoma classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]

Overview

Enteropathy-associated T-cell Lymphoma (EATL), also enteropathy-type T-cell lymphoma (ETTL), is a type of T-cell non-hodgkin lymphoma that affects the small intestine, it is composed of large lymphoid cells. Enteropathy-associated T-cell lymphoma has two subtypes, type I enteropathy-associated T-cell lymphoma which has a strong association with celiac disease and it is more common in western countries and type II enteropathy-associated T-cell lymphoma which is mostly found among the Asian population. Genes involved in the pathogenesis of this disease include 8q24, T-cell receptor (TCR) beta and gamma, and 16q genes. On gross pathology, multiple intestinal ulcers are characteristic findings of EATL. On microscopic histopathological analysis, monotonous cells, round or angulated vesicular nuclei, and prominent nucleoli are characteristic findings of enteropathy-associated T-cell lymphoma. There are no established causes for enteropathy-associated T-cell lymphoma. EATL must be differentiated from other diseases such as peptic ulcer, poorly-differentiated adenocarcinoma, MALT lymphoma, diffuse large B cell lymphoma, and mantle cell lymphoma.

Classification

  • Type I enteropathy-associated T-cell lymphoma
  • Type II enteropathy-associated T-cell lymphoma
Enteropathy-associated T-cell lymphoma classification[1][3][4]
Name Description
Classical enteropathy-associated T-cell lymphoma (Type I Enteropathy-associated T-cell lymphoma)
  • Covers 80-90% of all enteropathy-associated T-cell lymphoma cases.
  • Is usually associated with refractory celiac disease that is sometimes accompanied by intestinal ulceration (ulcerative jejunitis)
  • Most show adult onset disease or are diagnosed as having celiac disease in the same clinical episode in which the lymphoma is diagnosed.
  • Frequently has large-cell or pleomorphic cytology.
  • Seldom expresses CD8 and CD56.
Monomorphic enteropathy-associated T-cell lymphoma (Type II enteropathy-associated T-cell lymphoma)
  • Encountered in Asia and other regions where celiac disease is rare.
  • Is sporadic, seldom associated with celiac disease.
  • Covers 10-20% of all enteropathy-associated T-cell lymphoma cases.
  • Is characterized by monomorphic cytology.
  • Frequent expression of CD8 and CD56.
  • The tumor forms an ulcerating mucosal mass that invades the wall of the intestine.
  • Poor prognosis, death occurs from abdominal complications such as small bowel obstruction, perforation.

References

  1. 1.0 1.1 Enteropathy-associated T-cell lymphoma. BioMed Central. http://diagnosticpathology.biomedcentral.com/articles/10.1186/1746-1596-7-172. Accessed on January 28, 2016
  2. V G, Kudva R, Amprayil AJ (October 2014). "Enteropathy associated T cell lymphoma - a case report of an uncommon extranodal T cell lymphoma". J Clin Diagn Res. 8 (10): FD10–2. doi:10.7860/JCDR/2014/9740.4999. PMC 4253173. PMID 25478355.
  3. Enteropathy-associated T-cell lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd5315/. Accessed on January 26, 2016
  4. Hussain N, Hussain F, Chatterjee T, Upalakalin JN, Lynch T (2018). "An unexpected deterrent in diagnosing refractory celiac disease and enteropathy-associated T-cell lymphoma: a gluten-free diet". J Community Hosp Intern Med Perspect. 8 (4): 233–236. doi:10.1080/20009666.2018.1483693. PMC 6116147. PMID 30181834.